A 2-dose SARS-CoV-2 mRNA vaccine series was evaluated for antibody response in solid organ transplant recipients.
Does a 2-dose SARS-CoV-2 mRNA vaccine series improve antibody response in solid organ transplant recipients?
This study evaluates the antibody response to a 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients.
Absolute Event Rate: 0% vs 0%
This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.
Boyarsky et al. (Thu,) reported a other. A 2-dose SARS-CoV-2 mRNA vaccine series was evaluated for antibody response in solid organ transplant recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: